Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Edema | 3 | 2020 | 50 | 0.860 |
Why?
|
| Intracranial Hypertension | 2 | 2019 | 48 | 0.790 |
Why?
|
| Cerebral Hemorrhage | 6 | 2021 | 325 | 0.770 |
Why?
|
| Hyperammonemia | 1 | 2019 | 10 | 0.700 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2017 | 137 | 0.670 |
Why?
|
| Muscle Weakness | 2 | 2020 | 61 | 0.650 |
Why?
|
| Fever | 3 | 2020 | 125 | 0.630 |
Why?
|
| Arteriovenous Malformations | 1 | 2018 | 41 | 0.630 |
Why?
|
| Action Potentials | 2 | 2021 | 573 | 0.620 |
Why?
|
| Polyneuropathies | 1 | 2017 | 27 | 0.610 |
Why?
|
| Spine | 1 | 2018 | 102 | 0.610 |
Why?
|
| Neuromuscular Diseases | 1 | 2017 | 30 | 0.610 |
Why?
|
| Vascular Diseases | 1 | 2018 | 119 | 0.600 |
Why?
|
| Spinal Cord | 1 | 2018 | 249 | 0.580 |
Why?
|
| Cosmetics | 1 | 2016 | 7 | 0.570 |
Why?
|
| Persistent Vegetative State | 1 | 2016 | 9 | 0.570 |
Why?
|
| Alkaloids | 1 | 2016 | 45 | 0.570 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 15 | 0.570 |
Why?
|
| Benzodioxoles | 1 | 2016 | 16 | 0.570 |
Why?
|
| Pyrrolidines | 1 | 2016 | 58 | 0.550 |
Why?
|
| Liver Failure | 1 | 2016 | 78 | 0.540 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 114 | 0.530 |
Why?
|
| Facial Paralysis | 1 | 2015 | 17 | 0.520 |
Why?
|
| Posterior Cerebral Artery | 1 | 2014 | 2 | 0.520 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2014 | 6 | 0.520 |
Why?
|
| Anisocoria | 1 | 2014 | 2 | 0.510 |
Why?
|
| Reflex, Pupillary | 1 | 2014 | 7 | 0.510 |
Why?
|
| Masks | 1 | 2015 | 29 | 0.510 |
Why?
|
| Hyperventilation | 1 | 2014 | 13 | 0.510 |
Why?
|
| Coma | 1 | 2014 | 44 | 0.500 |
Why?
|
| Neurologic Examination | 1 | 2014 | 118 | 0.490 |
Why?
|
| Respiratory Mechanics | 1 | 2015 | 102 | 0.490 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 449 | 0.480 |
Why?
|
| Brain Diseases | 1 | 2014 | 180 | 0.450 |
Why?
|
| Hematoma | 2 | 2021 | 104 | 0.360 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 134 | 0.290 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 484 | 0.290 |
Why?
|
| Humans | 22 | 2021 | 86601 | 0.260 |
Why?
|
| Aged | 11 | 2021 | 18402 | 0.250 |
Why?
|
| Hospital Mortality | 3 | 2021 | 348 | 0.220 |
Why?
|
| Male | 12 | 2021 | 40956 | 0.220 |
Why?
|
| Middle Aged | 9 | 2021 | 25017 | 0.210 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2020 | 4 | 0.200 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2021 | 12 | 0.200 |
Why?
|
| Hypopituitarism | 1 | 2020 | 19 | 0.200 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 23 | 0.200 |
Why?
|
| Hypocalcemia | 1 | 2020 | 41 | 0.190 |
Why?
|
| Heart Conduction System | 1 | 2021 | 108 | 0.190 |
Why?
|
| Hemostatics | 1 | 2021 | 56 | 0.190 |
Why?
|
| Amantadine | 1 | 2020 | 18 | 0.190 |
Why?
|
| Nootropic Agents | 1 | 2020 | 10 | 0.190 |
Why?
|
| Primary Dysautonomias | 1 | 2020 | 6 | 0.190 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2020 | 16 | 0.180 |
Why?
|
| Adult | 7 | 2021 | 25640 | 0.180 |
Why?
|
| Head Injuries, Penetrating | 1 | 2020 | 54 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.180 |
Why?
|
| Hypothyroidism | 1 | 2020 | 232 | 0.170 |
Why?
|
| Electrocardiography | 1 | 2021 | 478 | 0.170 |
Why?
|
| Female | 10 | 2021 | 44507 | 0.160 |
Why?
|
| Heart Rate | 1 | 2021 | 492 | 0.160 |
Why?
|
| Brain Injuries | 1 | 2020 | 161 | 0.160 |
Why?
|
| Retrospective Studies | 7 | 2021 | 8475 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 86 | 0.160 |
Why?
|
| Cognition Disorders | 1 | 2020 | 236 | 0.160 |
Why?
|
| Early Ambulation | 1 | 2017 | 25 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6501 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 28 | 0.140 |
Why?
|
| Radiography | 2 | 2015 | 813 | 0.140 |
Why?
|
| Risk Factors | 4 | 2021 | 5416 | 0.140 |
Why?
|
| Vascular Fistula | 1 | 2015 | 12 | 0.130 |
Why?
|
| Esophageal Fistula | 1 | 2015 | 10 | 0.130 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 238 | 0.130 |
Why?
|
| Status Epilepticus | 1 | 2015 | 31 | 0.130 |
Why?
|
| Young Adult | 2 | 2017 | 5974 | 0.130 |
Why?
|
| Hospitalization | 1 | 2021 | 848 | 0.130 |
Why?
|
| Spirometry | 1 | 2015 | 66 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 20 | 0.130 |
Why?
|
| Decompressive Craniectomy | 1 | 2014 | 18 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2018 | 272 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2014 | 37 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 112 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2014 | 77 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 2600 | 0.120 |
Why?
|
| Critical Care | 1 | 2017 | 370 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2017 | 373 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 131 | 0.120 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 72 | 0.120 |
Why?
|
| Brain Stem | 1 | 2014 | 165 | 0.120 |
Why?
|
| Video Recording | 1 | 2014 | 190 | 0.110 |
Why?
|
| Echocardiography | 2 | 2015 | 911 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2015 | 233 | 0.110 |
Why?
|
| Cerebellum | 1 | 2014 | 247 | 0.110 |
Why?
|
| Prevalence | 3 | 2021 | 1239 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 288 | 0.100 |
Why?
|
| Brain Ischemia | 1 | 2015 | 398 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 1583 | 0.090 |
Why?
|
| Prognosis | 3 | 2021 | 3674 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 920 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 864 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 965 | 0.070 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 71 | 0.060 |
Why?
|
| Length of Stay | 2 | 2021 | 700 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 334 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 8979 | 0.060 |
Why?
|
| Disease Progression | 2 | 2021 | 1531 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2021 | 2261 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3352 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2020 | 11 | 0.050 |
Why?
|
| Electrolytes | 1 | 2020 | 52 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 64 | 0.050 |
Why?
|
| Patient Admission | 1 | 2021 | 112 | 0.050 |
Why?
|
| Life Support Care | 1 | 2021 | 49 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 81 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2020 | 111 | 0.050 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2020 | 5 | 0.050 |
Why?
|
| Ileus | 1 | 2020 | 9 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2020 | 22 | 0.050 |
Why?
|
| Plasmapheresis | 1 | 2020 | 26 | 0.050 |
Why?
|
| Neck Muscles | 1 | 2020 | 16 | 0.050 |
Why?
|
| Bradycardia | 1 | 2020 | 39 | 0.050 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2020 | 12 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2021 | 112 | 0.050 |
Why?
|
| Urinary Retention | 1 | 2020 | 40 | 0.050 |
Why?
|
| Tachycardia | 1 | 2020 | 35 | 0.050 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 66 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 41 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 70 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 341 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2020 | 270 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 826 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 272 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2020 | 170 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 297 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 300 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1673 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 41 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2021 | 7988 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 56 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 73 | 0.030 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 293 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 181 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 674 | 0.030 |
Why?
|
| Heart Atria | 1 | 2015 | 250 | 0.030 |
Why?
|
| Stents | 1 | 2015 | 377 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4210 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5209 | 0.030 |
Why?
|
| Comorbidity | 1 | 2015 | 943 | 0.030 |
Why?
|
| Hypertension | 1 | 2020 | 1141 | 0.020 |
Why?
|
| Hypoxia | 1 | 2014 | 641 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3636 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2015 | 2207 | 0.020 |
Why?
|